- Home
- COYA vs CBAT Comparison
COYA vs CBAT Comparison
Compare COYA & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- CBAT
- Stock Information
- Founded
- COYA 2020
- CBAT 1999
- Country
- COYA United States
- CBAT China
- Employees
- COYA N/A
- CBAT N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- CBAT Industrial Machinery/Components
- Sector
- COYA Health Care
- CBAT Miscellaneous
- Exchange
- COYA Nasdaq
- CBAT Nasdaq
- Market Cap
- COYA 107.0M
- CBAT 90.4M
- IPO Year
- COYA 2022
- CBAT N/A
- Fundamental
- Price
- COYA $5.61
- CBAT $0.88
- Analyst Decision
- COYA Strong Buy
- CBAT
- Analyst Count
- COYA 4
- CBAT 0
- Target Price
- COYA $16.50
- CBAT N/A
- AVG Volume (30 Days)
- COYA 116.6K
- CBAT 194.2K
- Earning Date
- COYA 11-05-2025
- CBAT 11-11-2025
- Dividend Yield
- COYA N/A
- CBAT N/A
- EPS Growth
- COYA N/A
- CBAT N/A
- EPS
- COYA N/A
- CBAT N/A
- Revenue
- COYA $423,452.00
- CBAT $145,462,366.00
- Revenue This Year
- COYA $40.80
- CBAT N/A
- Revenue Next Year
- COYA N/A
- CBAT $78.62
- P/E Ratio
- COYA N/A
- CBAT N/A
- Revenue Growth
- COYA N/A
- CBAT N/A
- 52 Week Low
- COYA $4.65
- CBAT $0.57
- 52 Week High
- COYA $10.24
- CBAT $1.30
- Technical
- Relative Strength Index (RSI)
- COYA 38.75
- CBAT 35.82
- Support Level
- COYA $5.37
- CBAT $0.88
- Resistance Level
- COYA $6.53
- CBAT $0.92
- Average True Range (ATR)
- COYA 0.43
- CBAT 0.04
- MACD
- COYA -0.12
- CBAT -0.00
- Stochastic Oscillator
- COYA 15.89
- CBAT 27.89
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.